Unlocking the power of nanomedicine: the future of nutraceuticals in oncology treatment
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62156489%3A43210%2F23%3A43924250" target="_blank" >RIV/62156489:43210/23:43924250 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.3389/fnut.2023.1258516" target="_blank" >https://doi.org/10.3389/fnut.2023.1258516</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3389/fnut.2023.1258516" target="_blank" >10.3389/fnut.2023.1258516</a>
Alternative languages
Result language
angličtina
Original language name
Unlocking the power of nanomedicine: the future of nutraceuticals in oncology treatment
Original language description
Cancer, an intricate and multifaceted disease, is characterized by the uncontrolled proliferation of cells that can lead to serious health complications and ultimately death. Conventional therapeutic strategies mainly target rapidly dividing cancer cells, but often indiscriminately harm healthy cells in the process. As a result, there is a growing interest in exploring novel therapies that are both effective and less toxic to normal cells. Herbs have long been used as natural remedies for various diseases and conditions. Some herbal compounds exhibit potent anti-cancer properties, making them potential candidates for nutraceutical-based treatments. However, despite their promising efficacy, there are considerable limitations in utilizing herbal preparations due to their poor solubility, low bioavailability, rapid metabolism and excretion, as well as potential interference with other medications. Nanotechnology offers a unique platform to overcome these challenges by encapsulating herbal compounds within nanoparticles. This approach not only increases solubility and stability but also enhances the cellular uptake of nutraceuticals, allowing for controlled and targeted delivery of therapeutic agents directly at tumor sites. By harnessing the power of nanotechnology-enabled therapy, this new frontier in cancer treatment presents an opportunity to minimize toxicity while maximizing efficacy. In conclusion, this manuscript provides compelling evidence for integrating nanotechnology with nutraceuticals derived from herbal sources to optimize cancer therapy outcomes. We explore the roadblocks associated with traditional herbal treatments and demonstrate how nanotechnology can help circumvent these issues, paving the way for safer and more effective cancer interventions in future oncological practice.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30401 - Health-related biotechnology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Frontiers in Nutrition
ISSN
2296-861X
e-ISSN
2296-861X
Volume of the periodical
10
Issue of the periodical within the volume
17 November
Country of publishing house
CH - SWITZERLAND
Number of pages
25
Pages from-to
1258516
UT code for WoS article
001111719500001
EID of the result in the Scopus database
2-s2.0-85178476879